missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD263 (TRAIL-R3) Polyclonal Antibody

Beschreibung
Reconstitute at 0.2 mg/mL in sterile PBS.
TRAIL-R3 (CD263) is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.
Spezifikation
Spezifikation
| Antigen | CD263 (TRAIL-R3) |
| Anwendungen | Immunohistochemistry (Paraffin), Neutralization, Western Blot |
| Klassifikation | Polyclonal |
| Konzentration | 0.2 mg/mL |
| Konjugat | Unconjugated |
| Zusammensetzung | PBS with trehalose and no preservative |
| Gen | TNFRSF10C |
| Gen-Zugriffsnummer | O14798 |
| Gen-Alias | Antagonist decoy receptor for TRAIL/Apo-2L; CD263; cytotoxic TRAIL receptor-3; DCR1; DCR1-TNFR; Decoy receptor 1; decoy TRAIL receptor without death domain; LIT; lymphocyte inhibitor of TRAIL; MGC149501; MGC149502; TNF receptor superfamily member 10c; TNF-related apoptosis-inducing ligand receptor 3; TNFRSF10C; TRAIL receptor 3; TRAIL receptor without an intracellular domain; TRAILR3; TRAIL-R3; TRID; Tumor necrosis factor receptor superfamily member 10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; UNQ321/PRO366 |
| Gensymbole | TNFRSF10C |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?